Mobile app for treating depression in cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the effectiveness of a mobile application called 'Moodivate' designed to assist cancer survivors experiencing depression. Participants will be randomly assigned to either use the app or not, with approximately two-thirds receiving the app. Throughout the 12-week study, all participants will complete electronic questionnaires to assess their depressive symptoms and experiences with the app. The study aims to address the unique mental health needs of individuals living with likely incurable cancer, who often face barriers to accessing traditional mental health treatments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years
* ILLIC (as determined during manual chart review)
* Elevated depressive symptoms, defined as a score of ≥ 8 on the PHQ-9
* Current owner of an iOS- or Android-compatible smartphone
* Willingness to utilize a mobile app for the treatment of depressed mood (response of "yes" on yes/no item)
* Have a valid e-mail address that is checked regularly or have regular access to text messages (to access follow-up assessments)
* English language fluency

Exclusion Criteria:

* Current suicidal ideation at study screening, defined as a response greater than or equal to 1 on item nine of the PHQ-9
* Severe cognitive impairment that precludes completion of informed consent. For the purposes of assessing eligibility, this criterion is operationalized as:
* Prior diagnosis of dementia, or Major Neurocognitive Disorder indicated either via self-report or in the EHR; or
* Self-report of cognitive difficulties that impair functional independence

Where it's running

• Medical University of South Carolina
  Charleston, South Carolina, United States Recruiting

Study contacts

• Study coordinator: Jennifer Dahne, Ph.D.
• Email: dahne@musc.edu
• Phone: 843-876-2280

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Metformin added to antidepressants for depression with obesity in Pakistani adults

  This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.

  Recruiting at 2 sites Riphah International University · Rawalpindi, Punjab Province and 1 other locations · NCT07654179

• Mindfulness‑augmented brain stimulation for treatment‑resistant depression

  This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.

  Recruiting Phase 2 University of California, San Diego · San Diego, California · NCT07512284

• Predicting depression in patients after heart surgery

  This study is trying to see if a new tool can help predict which patients might develop depression after heart surgery, so they can get help sooner.

  Recruiting University of Zurich · Zurich and 1 other locations · NCT06706323

• Behavioral Activation to prevent and treat depression in older adults

  This study is testing if a short therapy called Behavioral Activation can help older adults in Sweden prevent and treat depression while comparing it to their usual care.

  Recruiting Sormland County Council, Sweden · Eskilstuna, Sörmland · NCT06415838

• Oh Happy Day Class – Digital Connections for Depression in African Americans

  A mobile app delivers six weekly depression-therapy classes to African American adults to see if it helps reduce depressive symptoms.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT06206226

• Auricular acupuncture for treating depression during the Covid-19 pandemic

  This study is testing if auricular acupuncture can help university students with moderate depression feel better during the Covid-19 pandemic.

  Recruiting Universidade do Sul de Santa Catarina · Palhoça, Santa Catarina · NCT05855421

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.